Steven C. Katz

Insider Reports History

Location
Westminster, CO
Signature
/s/ Sean Murphy, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven C. Katz:

Company Role Class Num Shares Value Price $ Report Date Ownership
TriSalus Life Sciences, Inc. CHIEF MEDICAL OFFICER Common Stock 68,587 $377,229 $5.50 12 Feb 2024 Direct
TriSalus Life Sciences, Inc. CHIEF MEDICAL OFFICER Employee Stock Option (right to buy) 105,000 12 Feb 2024 Direct

Insider Reports Filed by Steven C. Katz

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TLSI TriSalus Life Sciences, Inc. 12 Feb 2024 2 $0 4 CHIEF MEDICAL OFFICER 14 Feb 2024, 18:13
TLSI TriSalus Life Sciences, Inc. 11 Aug 2023 1 $0 4 Chief Medical Officer 14 Aug 2023, 19:14
TLSI TriSalus Life Sciences, Inc. 10 Aug 2023 0 $0 3 Chief Medical Officer 14 Aug 2023, 19:12